Menu
Recruiting NCT05958901

Pulmonary Hypertension Observational Study

— Observational Pulmonary Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: pulmonary hypertension.
Who it may be relevant to
Registry conditions: Pulmonary Hypertension. Basic parameters: 20 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)

Overview

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Interventions

  • Other pulmonary hypertension
    The final outcome observed was a diagnosis of pulmonary hypertension.

Primary outcome measures

  • mean pulmonary arterial pressure [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
  • Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.

Exclusion criteria

  • Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
  • Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
  • Eye surgery in the last three months.
  • Retinal detachment myocardial infarction in the last 3 months.
  • Admission to hospital for any cardiac condition in the last month.
  • Heart rate over 120 beats per minute.
  • Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • The First Affiliated Hospital of Guangzhou Medical University — Guangzhou

Identifiers

NCT: NCT05958901 · Pulmonary Hypertension of GIRH

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗